BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Capolongo G, Capasso G, Viggiano D. A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics. Int J Mol Sci 2022;23:3915. [PMID: 35409276 DOI: 10.3390/ijms23073915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sadovskaya DS, Vishnevsky KA, Konakova IN, Bakulina NV. The rate of chronic kidney disease progression in advanced stages and the dynamics of the uremic syndrome parameters. Nefrologiâ (St -Peterbg ) 2022;26:50-65. [DOI: 10.36485/1561-6274-2022-26-4-50-65] [Reference Citation Analysis]
2 Zhu Y, Yang S, Lv L, Zhai X, Wu G, Qi X, Dong D, Tao X. Research Progress on the Positive and Negative Regulatory Effects of Rhein on the Kidney: A Review of Its Molecular Targets. Molecules 2022;27:6572. [PMID: 36235108 DOI: 10.3390/molecules27196572] [Reference Citation Analysis]
3 Uchida HA, Nakajima H, Hashimoto M, Nakamura A, Nunoue T, Murakami K, Hosoya T, Komoto K, Taguchi T, Akasaka T, Shiosakai K, Sugimoto K, Wada J; EX-DKD investigators. Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study. Adv Ther 2022;39:5158-75. [PMID: 36070133 DOI: 10.1007/s12325-022-02294-z] [Reference Citation Analysis]